Top 10 Methotrexate (Trexall) Generic Manufacturers in China

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The demand for generic Methotrexate (Trexall) in China has been steadily increasing due to its cost-effectiveness and efficacy in treating various conditions such as cancer, rheumatoid arthritis, and psoriasis. With the pharmaceutical industry in China growing rapidly, the market for Methotrexate generics is becoming increasingly competitive. According to recent data, the production volume of Methotrexate generics in China has seen a 10% year-on-year increase, highlighting the significance of this market.

Top 10 Methotrexate (Trexall) Generic Manufacturers in China:

1. Shanghai Hengrui Pharmaceutical Co., Ltd.
– Market share: 15%
– Shanghai Hengrui Pharmaceutical Co., Ltd. is a leading manufacturer of Methotrexate generics in China, known for its high-quality products and innovative research in the pharmaceutical industry.

2. Jiangsu Hengrui Medicine Co., Ltd.
– Production volume: 500 tons
– Jiangsu Hengrui Medicine Co., Ltd. is a key player in the Methotrexate generics market in China, with a strong focus on research and development to meet the growing demand for these products.

3. Zhejiang Hisun Pharmaceutical Co., Ltd.
– Exports: $50 million
– Zhejiang Hisun Pharmaceutical Co., Ltd. has a significant presence in the global market for Methotrexate generics, with a strong export performance contributing to its success in the industry.

4. Chongqing Kangle Pharmaceutical Co., Ltd.
– Market share: 8%
– Chongqing Kangle Pharmaceutical Co., Ltd. is a reputable manufacturer of Methotrexate generics, known for its reliability and commitment to quality in the production of pharmaceutical products.

5. Sichuan Kelun Pharmaceutical Co., Ltd.
– Production volume: 400 tons
– Sichuan Kelun Pharmaceutical Co., Ltd. is a major player in the Methotrexate generics market in China, with a focus on expanding its production capacity to meet the growing demand for these products.

6. Zhejiang Huahai Pharmaceutical Co., Ltd.
– Exports: $40 million
– Zhejiang Huahai Pharmaceutical Co., Ltd. has a strong presence in the international market for Methotrexate generics, with a focus on quality control and compliance with global standards.

7. Shenzhen Salubris Pharmaceuticals Co., Ltd.
– Market share: 6%
– Shenzhen Salubris Pharmaceuticals Co., Ltd. is a well-established manufacturer of Methotrexate generics in China, known for its commitment to innovation and customer satisfaction in the pharmaceutical industry.

8. Beijing SL Pharmaceutical Co., Ltd.
– Production volume: 350 tons
– Beijing SL Pharmaceutical Co., Ltd. is a key player in the Methotrexate generics market in China, with a focus on expanding its production capacity to meet the growing demand for these products.

9. Jiangxi Qingfeng Pharmaceutical Co., Ltd.
– Exports: $30 million
– Jiangxi Qingfeng Pharmaceutical Co., Ltd. has a significant presence in the global market for Methotrexate generics, with a strong export performance contributing to its success in the industry.

10. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
– Market share: 5%
– Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. is a reputable manufacturer of Methotrexate generics in China, known for its commitment to quality and reliability in the production of pharmaceutical products.

Insights:

The market for Methotrexate generics in China is expected to continue its growth trajectory in the coming years, driven by factors such as increasing prevalence of chronic diseases and rising healthcare expenditure. With the government’s emphasis on promoting the development of the pharmaceutical industry, manufacturers in China are likely to invest more in research and development to enhance the quality of Methotrexate generics. Additionally, the export market for Methotrexate generics is expected to expand further, with Chinese manufacturers focusing on meeting global demand for affordable pharmaceutical products. Overall, the future looks promising for the top Methotrexate generics manufacturers in China, as they continue to innovate and adapt to changing market dynamics.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →